Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.

Inclusion Criteria:

• Patients with CRLM
• Surgery: resection and/or ablation
• preoperative chemotherapy and/or biological agents are allowed
• postoperative chemotherapy and/or biological agents are allowed
• simultaneous colorectal resection is allowed

Exclusion Criteria:

• primary liver cancer
• benign liver tumors
• pregnancy